Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease

• Published in: Alzheimer's & dementia : diagnosis, assessment & disease monitoring Vol. 12; no. 1; pp. e12112 - n/a
• Main Authors: Moynier, Frédéric, Borgne, Marie Le, Lahoud, Esther, Mahan, Brandon, Mouton‐Ligier, Francois, Hugon, Jacques, Paquet, Claire
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 2020; Wiley; John Wiley and Sons Inc
• Subjects: Alzheimer's disease; amyloid beta; Body fluids; Brain research; copper; Dementia; Diagnostic Assessment & Prognosis; Homeostasis; Isotopes; Life Sciences; Medical research; Neurobiology; Neurons and Cognition; Neuropathology; Short Report; Zinc; France; Paris France; copper; Alzheimer's disease; isotopes; amyloid beta
• ISSN: 2352-8729; 2352-8729
• DOI: 10.1002/dad2.12112

Introduction Alzheimer's disease (AD) is neuropathologically marked by amyloid beta (Aβ) plaques and neurofibrillary tangles. Little is known about isotopic compositions of human AD brains. Here we study this in comparison with control subjects for copper and zinc. Methods We use mass‐spectrometry methods, developed to study extraterrestrial materials, to compare the copper and zinc isotopic composition of 10 AD and 10 control brains. Results Copper and zinc natural isotopic compositions of AD brains are statistically different compared to controls, and correlate with Braak stages. Discussion The distribution of natural copper and zinc isotopes in AD is not affected by the diet, but is a consequence of Aβ plaques and tau fibril accumulation. This is well predicted by the changes of the chemical bonding environment caused by the development of Aβ lesions and accumulation of tau proteins. Future work will involve testing whether these changes affect brain functions and are propagated to body fluids.